Intl. Biotechnology Trust PLC Compliance with the Market Abuse Regulation (1184Q)
13 Octubre 2023 - 8:22AM
UK Regulatory
TIDMIBT
RNS Number : 1184Q
Intl. Biotechnology Trust PLC
13 October 2023
13 October 2023
INTERNATIONAL BIOTECHNOLOGY TRUST PLC
("IBT" or the "Company")
Compliance with the Market Abuse Regulation ("MAR")
The Company announces that it is satisfied that all inside
information which the Directors and the Company may have had in the
period leading up to the announcement of the Annual Financial
Report for the year ended 31 August 2023 has been notified to a
Regulated Information Service ("RIS"). The Company is therefore not
prohibited from purchasing its own securities or re-selling
treasury shares during the closed period (as defined by MAR) which
ends on the date of the announcement of the Annual Financial
Report.
If, in the period leading up to the announcement of the Annual
Financial Report, the Directors or the Company come into possession
of any inside information, this will be notified to a RIS before
any such transactions are undertaken.
Pursuant to the share buyback authority granted by shareholders
of the Company on 6 December 2022, the Company has appointed Numis
Securities Limited to manage an irrevocable, non-discretionary
share buyback programme until the date on which the Company's
Annual Financial Report is published. The Company and its Directors
have no power to invoke any changes to the programme, which is
being undertaken at the sole discretion of Numis Securities
Limited.
The closed period to which this notification relates is in
respect of the year ended 31 August 2023.
For further information contact:
Company Secretary - Link Company Matters
Indu Shastri +44 (0)7936 045789
LEI: 213800N1QUJ744P76D11
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
CMCFFFFDDEDSEES
(END) Dow Jones Newswires
October 13, 2023 09:22 ET (13:22 GMT)
International Biotechnol... (LSE:IBT)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
International Biotechnol... (LSE:IBT)
Gráfica de Acción Histórica
De May 2023 a May 2024